The Engineering Powerhouse Behind Spyder ECG​

Headquartered in Singapore, Web Biotechnology Pte. Ltd. is a medical technology pioneer specializing in advanced cardiac diagnostics. We are the creators and engineers behind Spyder ECG, a unified, medical-grade ecosystem that integrates proprietary wearable hardware, advanced signal processing, and cloud-based, AI-driven analytics to enable early detection and scalable remote patient management.

 

To meet the accelerating global demand for continuous cardiac care, we established our strategic subsidiary, Wanxinbo (万心波), in China. This entity leverages China’s elite medical manufacturing ecosystem to manufacture and commercialize our Spyder ECG solutions locally, securing regulatory alignment with the National Medical Products Administration (NMPA). This dual-presence model enables high-scale production, faster regional distribution, and seamless integration of the Spyder platform into major hospital networks across Asia.

 

At Web Biotechnology, our mission is to deliver highly accessible, costeffective, and clinically robust Mobile Cardiac Telemetry (MCT) solutions. By combining our reliable, wire-free Spyder ECG hardware with intelligent automated insights, we empower healthcare providers worldwide to conduct large-scale screenings and deliver life-saving cardiovascular diagnoses.

Validated by World-Class Regulatory Standards​

Patient safety, data integrity, and clinical precision are the core pillars of the Spyder ECG platform. Our technology is built to meet the most stringent healthcare benchmarks, ensuring total peace of mind for both clinicians and patients.

Current Regulatory Approvals

HSA Certified (Singapore), The Spyder ECG System is fully registered and approved by the Health Sciences Authority (HSA) of Singapore as a certified medical device. This validation guarantees that our wearable hardware, cloud systems, and diagnostic reporting meet top tier international metrics for clinical efficacy and patient safety.

Global Standards & Data Security

Clinical-Grade Governance, Our advanced ECG core lab reports are verified by certified cardiologists, adhering to rigorous medical data protocols.

Enterprise Security Architecture, Built with end-to-end data encryption to comply with strict medical privacy standards, securing patient data from capture to cloud archiving.

Future Global Expansion, Backed by our strategic infrastructure in Singapore and China, we are actively aligning our manufacturing and software ecosystems with major regional and global regulatory frameworks (including NMPA) to expand our footprint.

Expanding Access to Next Generation Cardiac Care​

The Spyder ECG ecosystem is rapidly expanding its international footprint through a robust and growing network of certified medical distributors, clinical partners, and major hospital groups.

With operational coverage spanning Southeast Asia (including Singapore,
Vietnam, Indonesia, Thailand, and Malaysia), alongside key international markets in Taiwan, Qatar, the United Kingdom (UK), and Canada, we work hand-in-hand with trusted local partners. This global network guarantees prompt regional logistics, responsive technical support, and seamless deployment that aligns perfectly with the specific regulatory and operational needs of cardiac care providers worldwide.

Spyder ECG Global Footprint

Delivering secure, contact-free remote cardiac telemetry across borders.

Partner With Us

Looking to deploy Spyder ECG at your medical facility, or interested in becoming an authorized regional distributor?